Healthcare, Pharma & Life Sciences

Creek Equity Maps Healthcare Portfolio Across Supply Chain, PBM

Image
Creek Equity Maps Healthcare Portfolio Across Supply Chain, PBM

Bloomfield Hills – October 29, 2026 -- Creek Equity, the private investment company owned by investor Scott Zack, has detailed a healthcare services portfolio that spans supply chain, pharmacy benefit management and medical courier logistics, funded with the firm's own capital.

Creek Equity runs three healthcare operating companies

Avenix Medical Group provides strategic sourcing, supplier visibility, risk monitoring and continuity planning to hospitals, health systems, physician groups and post-acute care providers.

Movanti Group is a pharmacy benefit manager for employers, unions and benefit funds. It operates on a 100 percent pass-through model.

Total Routing Solutions handles specimen pickup and delivery for clinical laboratories and other healthcare companies.

EVERSANA Acquires AI-Driven HEOR Firm Estima Scientific

Image
EVERSANA Acquires AI-Driven HEOR Firm Estima Scientific

Chicago – October 29, 2026 -- EVERSANA has acquired London-based health economics and outcomes research (HEOR) technology company Estima Scientific, adding generative-AI tools for economic modeling, systematic literature reviews and network meta-analysis to its market access offering. Financial terms were not disclosed.

Estima's web-based generative-AI applications integrate proprietary code. Its consulting expertise and software will be folded into EVERSANA's market access and value & evidence solutions. The aim is to help pharmaceutical companies show a drug's clinical and economic value to payers more efficiently and transparently.

Sound Physicians Names Emil Engels Chief Physician Officer at Anesthesia Unit

Image
Sound Physicians Names Emil Engels Chief Physician Officer at Anesthesia Unit

Nashville – October 29, 2026 -- Sound Physicians has appointed Emil Engels, MD, MBA, as Chief Physician Officer for Sound Anesthesia, a newly created post that places a physician executive alongside a CRNA executive at the top of the unit's clinical leadership.

Engels joined in September and shares leadership with Chief Anesthetist Officer Noele Morse

Engels is a cardiac anesthesiologist with more than 25 years of experience leading anesthesia practices and healthcare organizations. He joined the medical group in September to work with Sound Anesthesia's physician leaders on operational excellence and clinical quality initiatives. He will work alongside Noele Morse, DNP, CRNA, the unit's Chief Anesthetist Officer. The same collaborative model extends to the associate-level roles.

AOK Federal Association CEO Reimann Won't Seek Second Term

Image
AOK Federal Association CEO Reimann Won't Seek Second Term

Berlin – October 29, 2026 -- Carola Reimann, chair of the executive board of the AOK-Bundesverband, will leave the post when her contract ends, after six years in the role. She cited personal reasons and will not run again for the association's executive board.

Reimann's contract runs to the end of 2027

Reimann, 59, has led the board since January 2022. She will continue her duties unchanged until her contract expires. She described working for the AOK community and the federal association as one of the most rewarding assignments in the German healthcare system, and said the decision was not easy.

Early announcement is meant to allow a seamless handover

Reimann has already informed the responsible committees and the association's staff. According to the association, the early notice allows prompt succession planning and a seamless transition.

KPM Analytics launches UCAL 5 NIR calibration platform

Image
KPM Analytics launches UCAL 5 NIR calibration platform

Westborough, Mass. – October 29, 2026 -- KPM Analytics has released UCAL 5, a near-infrared (NIR) calibration platform for SpectraStar XT Series analyzers that checks every calibration against ASTM E1655 and ISO 12099 recommendations as the user works. The patent-pending guided workflow takes users from KPM calibration libraries to a published calibration for their own products in four steps. A 30-day free trial of UCAL 5 Pro is available now to current SpectraStar XT users.

UCAL Insight flags weak calibrations with green, yellow and red marks

UCAL Insight checks whether a calibration has enough samples, how well laboratory values cover the required range, and whether new samples confirm the calibration. Each point is marked green, yellow or red with an explanation. The marks are suggestions, and the user makes the final decision.

Sciensus names ex-HC-One chief James Tugendhat as CEO

Image
Sciensus names ex-HC-One chief James Tugendhat as CEO

London – October 29, 2026 -- Sciensus has appointed James Tugendhat OBE as Chief Executive Officer, bringing in an executive with more than 20 years of leadership experience across healthcare and complex service organisations.

Former HC-One group CEO replaces interim chief Gordon Cox

Tugendhat was most recently Group CEO of HC-One, the UK's largest care home operator. He previously held senior positions at Bupa, including CEO of Health Dialog, a US health analytics and chronic disease management company. He also spent seven years as a non-executive director of the Royal Free London NHS Foundation Trust.

Gordon Cox led Sciensus as interim CEO while the Board searched for a permanent successor. Cox continues as Chief Operating Officer and as a member of key company boards.

CarePatrol Enters Nevada as State Permits Senior Placement Services

LAS VEGAS – October 29, 2026 -- CarePatrol, a Best Life Brands company, can now offer senior care advisory services in Nevada, where placement services became permitted for the first time.

Governor's office honors Henderson franchisee at 2026 conference

Liz Gabrielle Payumo, Southern Outreach Coordinator for the Nevada Governor's Office, welcomed CarePatrol to the state on the opening night of its annual conference in Las Vegas on October 1-2. She presented Michelle Kiel, owner of CarePatrol of Clark County East - Henderson, with a certificate of recognition from Governor Joe Lombardo's office.

Payumo cited the organization's more than 30 years of helping families with senior care decisions.

Suvoda Adds Lyft, Uber Health, Bolt to Greenphire Travel

Image
Suvoda Adds Lyft, Uber Health, Bolt to Greenphire Travel

CONSHOHOCKEN, Pa. – October 29, 2026 -- Suvoda has added Lyft, Uber Health and Bolt rideshare access to Greenphire Travel, targeting a logistical barrier that 49% of disrupted participants in the latest CISCRP study cited: travel to the study clinic.

Participants book rides and track trips through the Suvoda App

Participants can book eligible rides, view flight and hotel details, and follow rideshare status in the Suvoda App. The same app shows study appointments, questionnaires and payments. Suvoda says this cuts routine status inquiries routed through site staff. Rideshare provider availability depends on region.

Sites get a revised travel request workflow, a clearer view of trip status and secure messaging. Sponsors and contract research organizations (CROs) get more detailed reporting on travel spend and policy across global trials.

Harvard Pilgrim Enrolls 2,000+ Members in Hinge Health Since July

Image
Harvard Pilgrim Enrolls 2,000+ Members in Hinge Health Since July

CANTON, Mass. – October 29, 2026 -- More than 2,000 Harvard Pilgrim Health Care members have enrolled in the Hinge Health digital musculoskeletal (MSK) program since its July launch, the Point32Health company said as it announced new and expanded clinical partnerships.

Hinge Health MSK program comes at no added cost to members

The program combines personalized exercise therapy with a care team of physical therapists and health coaches. It covers injury prevention, MSK pain management, mobility improvement, and rehabilitation before or after surgery. Members get 24/7 access, movement analysis to track progress, real-time feedback on exercises and adherence, and referrals to in-person care when needed.

Formation Bio Launches $600M Fund to Acquire 10-15 Drug Programs

Image
Formation Bio Launches $600M Fund to Acquire 10-15 Drug Programs

New York – October 29, 2026 -- Formation Bio, an AI-native pharmaceutical company, has launched the Formation Bio Drug Development Accelerator Fund with $600 million in capital commitments to expand its portfolio of clinical-stage medicines. The company aims to acquire 10-15 drug programs over the next 3-5 years and advance them through key clinical milestones.

Fund draws research foundations, endowments and hospitals as limited partners

The Fund's limited partners include research foundations, institutional endowments, hospitals and philanthropic organizations. Formation Bio acts as general partner through a wholly owned subsidiary and has committed its own capital alongside them. The amount of that commitment was not disclosed.

The Fund exclusively finances the acquisition and development of programs within Formation Bio's portfolio, scaling the company's hub-and-spoke model.